Indeed, our unbiased ex vivo liver-CM system, inspired by Male’s group [41], recaptured a similar CCR5-KO phenotype described above in primary hepatocytes under the NAFLD microenvironment. The gene discussed is CCR5; the disease is metabolic dysfunction-associated steatotic liver disease.